Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Among the Top Nine Nationwide! Healthy Yuan Selected for the 2019 Top 100 Chinese Chemical Pharmaceutical Enterprises Ranking

Published Time:

2020-09-03

The 2020 National Pharmacy Week and the Annual Meeting of China's Top 100 Pharmaceutical Companies and the Annual Meeting of China's Pharmaceutical Internet Economy were grandly held in Kunming, Yunnan, China from August 25th to 28th. At the same time, the highly anticipated 2019 China's Top 100 Pharmaceutical Companies list was released!

 

Jiankangyuan Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jiankangyuan"), with its solid R&D and production capabilities and stable market promotion capabilities, was successfully selected for the "2019 China's Top 100 Pharmaceutical Companies" sub-list, ranking Top 9 in the "2019 Top 100 Chinese Chemical Pharmaceutical Companies"!

 

It is understood that the Mi Nei Research Institute organized the Expert Committee of the China's Top 100 Pharmaceutical Companies Ranking. Relying on the three major terminal and six major market terminal pattern databases that Mi Nei.com has been exclusively developing and operating in China for many years, the committee selected the "2019 China's Top 100 Pharmaceutical Companies" from two of the most important dimensions (innovation driving force and professional promotion capability).

 

The "2019 China's Top 100 Pharmaceutical Companies" consists of 5 sub-lists:
"Top 100 Chinese Chemical Pharmaceutical Companies", "Top 100 Chinese Traditional Chinese Medicine Companies", "Top 20 Chinese CRO (including CDMO) Companies", "Top 20 Chinese Medical Devices (including IVD) Companies", and "Top 20 Chinese Biopharmaceutical (including blood products, vaccines, insulin, etc.) Companies".

The total score of the selected companies consists of two parts: one is the company's innovation driving force, namely the 2019 R&D investment R&D comprehensive index score, accounting for 40% of the weight; the other is the company's professional promotion capability, which is rigidly defined by the quantitative data of the final choices of clinical doctors and patients in 2019, that is, the score obtained by quantitative analysis combining Mi Nei.com's exclusive data from three major terminals and six major market terminals, accounting for 60% of the weight.

 

The selection of the "2019 China's Top 100 Pharmaceutical Companies" has received high attention and active participation from professional research institutions, industry experts and scholars, entrepreneurs, and industry colleagues, and has been highly praised. This selection event has had a significant impact.

 

Jiankangyuan, which won the ninth place nationwide this time, is a comprehensive pharmaceutical group company integrating R&D, production, sales, and service. To seize the development opportunities in the respiratory drug market, in recent years, it has been adhering to the breakthrough of characteristic and innovative R&D technology platforms such as the respiratory drug delivery technology platform, continuously deploying in the respiratory field. After years of development, the company has now formed a relatively focused and clear product R&D pipeline, and its inhalation preparation business is gradually entering the harvest period.

 

After the epidemic, with the drastic deepening and transformation of many industrial policies, the pharmaceutical and health industry needs to return to its industry essence, industrial value, and health goals. Jiankangyuan, which has been deeply involved in the great health field for many years, remains unchanged in its original intention. Being selected for this list is a unanimous recognition by the market of the company's hard work and exemplary role for society and the industry in recent years.